ESR1 and breast carcinoma: Having previously demonstrated the co-expression status of Lin28A and androgen receptor (AR) in ER−/Her2+ breast cancer [13], this study showed that Lin28A can induce the expression of AR via regulation of c-myc in ER−/Her2+ breast cancer.